Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | CFTR | P13569 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA5A | P35218 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.47 |
| ▸ | MYC | P01106 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28371090 | 0.98 | TSHR (0.55) | TSHRLMNAALDH1A1HSD17B10CFTR | |
| SCHEMBL2244750 | 0.86 | ALDH1A1 (0.45) | TSHRLMNAALDH1A1HSD17B10CFTR | |
| SCHEMBL27909331 | 0.85 | MAPT (0.43) | TSHRLMNAALDH1A1HSD17B10CFTR | |
| SCHEMBL14976 | 0.84 | MAPT (0.44) | TSHRLMNAALDH1A1KDM4EPOLB | |
| SCHEMBL29448528 | 0.84 | MAPT (0.44) | TSHRLMNAALDH1A1KDM4EPOLB | |
| SCHEMBL22745916 | 0.83 | LMNA (0.52) | TSHRLMNAALDH1A1HSD17B10CFTR | |
| SCHEMBL28465355 | 0.83 | CA2 (0.55) | TSHRLMNAALDH1A1HSD17B10CFTR | |
| SCHEMBL11640332 | 0.82 | TSHR (0.55) | TSHRLMNAALDH1A1HSD17B10CFTR | |
| SCHEMBL10938198 | 0.82 | TSHR (0.55) | TSHRLMNAALDH1A1HSD17B10CFTR | |
| SCHEMBL12988542 | 0.82 | TSHR (0.42) | TSHRLMNAALDH1A1HSD17B10POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113754521-B | Synthesis process method of avobenzone | 马鞍山科思化学有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-113754521-A | Synthetic process method of avobenzone | 马鞍山科思化学有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-120082243-A | High-gloss paint for motorcycle and spraying process thereof | 浙江铠甲汽车零部件有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-116063160-B | Aromatic enol sodium salt and synthesis method thereof | 马鞍山科思化学有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-113754521-B | Synthesis process method of avobenzone | 马鞍山科思化学有限公司 | 2023-12-19 | — | — | CN | disclosed |
| US-11701370-B2 | Phosphonium ion channel blockers and methods for use | Nocion Therapeutics, Inc. (US) | 2023-07-18 | — | — | US | disclosed |
| US-11701370-B2 | Phosphonium ion channel blockers and methods for use | Nocion Therapeutics, Inc. (US) | 2023-07-18 | — | — | US | disclosed |
| US-20230183282-A1 | REMDESIVIR AND REMDESIVIR ANALOGS, SOLUTIONS, AND NANOPARTICLE, LIPOSOMAL, AND MICROPARTICLE COMPOSITIONS FOR TREATING VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2023-06-15 | — | — | US | disclosed |
| US-20230183282-A1 | REMDESIVIR AND REMDESIVIR ANALOGS, SOLUTIONS, AND NANOPARTICLE, LIPOSOMAL, AND MICROPARTICLE COMPOSITIONS FOR TREATING VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2023-06-15 | — | — | US | disclosed |
| US-20230150935-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-05-18 | — | — | US | disclosed |
| US-20230150935-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-05-18 | — | — | US | disclosed |
| US-20070135631-A1 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2007-06-14 | — | — | US | disclosed |
| US-20070037794-A1 | 4-((5-Chloro-3-(4-methyl-3-trifluoromethylbenzenesulfonylamino)pyridin-2-yl)-oxo-)1H-pyrrolo(2,3-)pyridine;interfere with ligand (monocyte chemoatactic protein-1) for chemokine receptors (CCR2); antiinflammatory agents; immunomodulators; bactericides; viricides; fungicides | CHEMOCENTRYX, INC. | 2007-02-15 | — | — | US | disclosed |
| US-20070027321-A1 | Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 | MERCK SHARP & DOHME CORP. | 2007-02-01 | — | — | US | disclosed |
| US-4742139-A | COORDINATION CATALYSTS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-05-03 | — | — | US | disclosed |
| US-4526882-A | Contacting magnesium alcoholate and group II or group IIIA metal alkyl, treating with titanium halide and electron donor, comminuting, treating product with titanium halide, ethyl benzoate, aromatic acid ester | STANDARD OIL COMPANY (INDIANA) (US) | 1985-07-02 | — | — | US | disclosed |
| EP-0022675-B1 | PROCESS FOR PRODUCING OLEFIN POLYMERS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1984-05-16 | — | — | EP | disclosed |
| US-4401589-A | Process for producing olefin polymers or copolymers | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1983-08-30 | — | — | US | disclosed |
| US-4330649-A | IN THE PRESENCE OF A TITANIUM, MAGNESIUM, ELECTRON DONOR COMPLEX CATALYST | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1982-05-18 | — | — | US | disclosed |
| EP-0022675-A1 | Process for producing olefin polymers | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1981-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135631-A1 | HETEROCYCLIC CETP INHIBITORS | CETP, CES1, NPC1 | TSHR 2250/4885LMNA 170/4885ALDH1A1 2353/4885 |
| US-20070037794-A1 | 4-((5-Chloro-3-(4-methyl-3-trifluoromethylbenzenesulfonylamino)pyridin-2-yl)-oxo-)1H-pyrrolo(2,3-)pyridine;interfere with ligand (monocyte chemoatactic protein-1) for chemokine receptors (CCR2); antiinflammatory agents; immunomodulators; bactericides; viricides; fungicides | CCR2, CCR1, CCL2 | TSHR 1824/4885LMNA 4844/4885ALDH1A1 1867/4885 |
| US-20230150935-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CALCIUM ION HOMEOSTASIS | CHERP, ATP2A1, ATP2A3 | TSHR 4002/4885LMNA 1974/4885ALDH1A1 3911/4885 |
| US-20070027321-A1 | Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 | GRM5, GRIK5, GRM1 | TSHR 692/4885LMNA 4645/4885ALDH1A1 2178/4885 |
| US-11701370-B2 | Phosphonium ion channel blockers and methods for use | TRPV1, TRPV5, TRPA1 | TSHR 4454/4885LMNA 3757/4885ALDH1A1 3411/4885 |
| US-20230183282-A1 | REMDESIVIR AND REMDESIVIR ANALOGS, SOLUTIONS, AND NANOPARTICLE, LIPOSOMAL, AND MICROPARTICLE COMPOSITIONS FOR TREATING VIRAL INFECTIONS | ALB, ACE, ACE2 | TSHR 4564/4885LMNA 1093/4885ALDH1A1 3327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.